BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 30, 2026
Home
»
Topics
»
Disease categories and therapies
» Nephrology
Nephrology
RSS
Positive phase III topline results for Alprox-TD
June 17, 2003
Two series of ALK5 kinase inhibitors and their use described by GSK team
June 12, 2003
Ortho-McNeil scientists prepare and test novel PDE5 inhibitors
June 12, 2003
New PDE5 inhibitors in Schering-Plough development pipeline
June 11, 2003
Intranasal apomorphine enters new phase II study in erectile dysfunction
June 6, 2003
Influence of sildenafil on duodenal function and cirrhotic portal hemodynamics
June 4, 2003
Topiglan enters new phase II study for erectile dysfunction
June 4, 2003
No evidence of carcinogenicity in NexACT rat study
June 2, 2003
Phase II efficacy data reported for intranasal apomorphine in FSD
June 2, 2003
Oxytrol submission accepted for review in Canada
May 28, 2003
Previous
1
2
…
227
228
229
230
231
232
233
234
235
…
337
338
Next